| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel [M. M., I. S., N. E., X. T., S. S., A. M., Y. T., N. G., D. G., V. R.], and the Laboratory of Human Carcinogenesis, National Cancer Institute, NIH, Bethesda, Maryland 20892 [C. C. H.]
Telomere shortening in primary human fibroblasts results in replicative senescence, which can be overcome by telomerase (hTERT) overexpression. However, because immortalization is one of the hallmarks of malignant transformation, careful analysis of hTERT-immortalized cells is of crucial importance for understanding both processes. To this end, we infected WI-38 fibroblasts with a retrovirus carrying the hTERT cDNA and analyzed their proliferative behavior during 600 days [
500 population doublings (PDLs)] of continuous culture. Growth of three independent mass cultures was uniform for
150 PDLs after telomerase infection, followed by a progressive acceleration of growth in two of three cultures. Expression of p16INK4A was significantly elevated in the immortalized cells but gradually disappeared during the accelerated growth phase. This alteration correlated with loss of the contact inhibition response and conferred the cells with sensitivity to H-Ras-induced transformation. In contrast, the p53- and pRb-mediated checkpoints such as the DNA damage response, chromosomal stability and entry into quiescence remained intact, irrespective of INK4A locus expression. Importantly, detailed examination of one of the WI-38/hTERT cultures during the accelerated growth phase revealed overexpression of the c-myc and Bmi-1 oncogenes, as well as loss of p14ARF expression. Collectively, our results indicate that although hTERT-immortalized cells behave similarly to primary cells during the first 150 PDLs, long-term growth in culture may favor the appearance of clones carrying potentially malignant alterations.
This article has been cited by other articles:
![]() |
X. Liu, A. Dakic, R. Chen, G. L. Disbrow, Y. Zhang, Y. Dai, and R. Schlegel Cell-Restricted Immortalization by Human Papillomavirus Correlates with Telomerase Activation and Engagement of the hTERT Promoter by Myc J. Virol., December 1, 2008; 82(23): 11568 - 11576. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Shema, I. Tirosh, Y. Aylon, J. Huang, C. Ye, N. Moskovits, N. Raver-Shapira, N. Minsky, J. Pirngruber, G. Tarcic, et al. The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression Genes & Dev., October 1, 2008; 22(19): 2664 - 2676. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. G. Fridlender, P. Y. Cohen, O. Golan, N. Arish, S. Wallach-Dayan, and R. Breuer Telomerase activity in bleomycin-induced epithelial cell apoptosis and lung fibrosis Eur. Respir. J., August 1, 2007; 30(2): 205 - 213. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Moskovits, A. Kalinkovich, J. Bar, T. Lapidot, and M. Oren p53 Attenuates Cancer Cell Migration and Invasion through Repression of SDF-1/CXCL12 Expression in Stromal Fibroblasts. Cancer Res., November 15, 2006; 66(22): 10671 - 10676. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. W. Wen, K. Wu, S. Baksh, R. A. Hinshelwood, R. B. Lock, S. J. Clark, M. A.S. Moore, and K. L. MacKenzie Telomere-Driven Karyotypic Complexity Concurs with p16INK4a Inactivation in TP53-Competent Immortal Endothelial Cells. Cancer Res., November 15, 2006; 66(22): 10691 - 10700. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Buganim, E. Kalo, R. Brosh, H. Besserglick, I. Nachmany, Y. Rais, P. Stambolsky, X. Tang, M. Milyavsky, I. Shats, et al. Mutant p53 Protects Cells from 12-O-Tetradecanoylphorbol-13-Acetate-Induced Death by Attenuating Activating Transcription Factor 3 Induction. Cancer Res., November 15, 2006; 66(22): 10750 - 10759. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Menzel, M. Migliaccio, D. R. Goldstein, S. Dahoun, M. Delorenzi, and N. Rufer Mechanisms Regulating the Proliferative Potential of Human CD8+ T Lymphocytes Overexpressing Telomerase J. Immunol., September 15, 2006; 177(6): 3657 - 3668. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Kogan, N. Goldfinger, M. Milyavsky, M. Cohen, I. Shats, G. Dobler, H. Klocker, B. Wasylyk, M. Voller, T. Aalders, et al. hTERT-Immortalized Prostate Epithelial and Stromal-Derived Cells: an Authentic In vitro Model for Differentiation and Carcinogenesis. Cancer Res., April 1, 2006; 66(7): 3531 - 3540. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Y. Klinger, J. L. Blum, B. Hearn, B. Lebow, and L. E. Niklason Tissue Engineering Special Feature: Relevance and safety of telomerase for human tissue engineering PNAS, February 21, 2006; 103(8): 2500 - 2505. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Umemoto, M. Yamato, K. Nishida, J. Yang, Y. Tano, and T. Okano Limbal Epithelial Side-Population Cells Have Stem Cell-Like Properties, Including Quiescent State Stem Cells, January 1, 2006; 24(1): 86 - 94. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zongaro, E. de Stanchina, T. Colombo, M. D'Incalci, E. Giulotto, and C. Mondello Stepwise Neoplastic Transformation of a Telomerase Immortalized Fibroblast Cell Line Cancer Res., December 15, 2005; 65(24): 11411 - 11418. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. J. Schreurs, M. A. J. A. Hermsen, R. I. K. Geltink, K. B. J. Scholten, A. A. T. P. Brink, E. W. M. Kueter, M. Tijssen, C. J. L. M. Meijer, B. Ylstra, G. A. Meijer, et al. Genomic stability and functional activity may be lost in telomerase-transduced human CD8+ T lymphocytes Blood, October 15, 2005; 106(8): 2663 - 2670. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Milyavsky, Y. Tabach, I. Shats, N. Erez, Y. Cohen, X. Tang, M. Kalis, I. Kogan, Y. Buganim, N. Goldfinger, et al. Transcriptional Programs following Genetic Alterations in p53, INK4A, and H-Ras Genes along Defined Stages of Malignant Transformation Cancer Res., June 1, 2005; 65(11): 4530 - 4543. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Rubio, J. Garcia-Castro, M. C. Martin, R. de la Fuente, J. C. Cigudosa, A. C. Lloyd, and A. Bernad Spontaneous Human Adult Stem Cell Transformation Cancer Res., April 15, 2005; 65(8): 3035 - 3039. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Burns, B. M. Abdallah, P. Guldberg, J. Rygaard, H. D. Schroder, and M. Kassem Tumorigenic Heterogeneity in Cancer Stem Cells Evolved from Long-term Cultures of Telomerase-Immortalized Human Mesenchymal Stem Cells Cancer Res., April 15, 2005; 65(8): 3126 - 3135. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Q. Piao, L. Liu, Y. L. Zhao, A. S. Balajee, M. Suzuki, and T. K. Hei Immortalization of human small airway epithelial cells by ectopic expression of telomerase Carcinogenesis, April 1, 2005; 26(4): 725 - 731. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Taylor, A. James, C. E. Schuller, J. Brce, R. B. Lock, and K. L. MacKenzie Inactivation of p16INK4a, with Retention of pRB and p53/p21cip1 Function, in Human MRC5 Fibroblasts That Overcome a Telomere-independent Crisis during Immortalization J. Biol. Chem., October 15, 2004; 279(42): 43634 - 43645. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |